PMEF
ACET icon

Point72 Middle East FZE’s Adicet Bio ACET Stock Holding History

Point72 Middle East FZE’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-289
Closed -$8.74K – 17
2023
Q4 		$8.74K Sell
289
-423
-59% -$9.22K ﹤0.01% 1402
2023
Q3 		$15.6K Buy
+712
New +$25.1K ﹤0.01% 1329
2023
Q2 		– Sell
-598
Closed -$55.1K – 1489
2023
Q1 		$55.1K Sell
598
-170
-22% -$21.3K ﹤0.01% 1251
2022
Q4 		$110K Buy
+768
New +$192K ﹤0.01% 1237

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Middle East FZE's ACET Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Adicet Bio (ACET) in Q1 2024, closing a stake of 289 shares — an estimated $8.74K sold.

Point72 Middle East FZE first reported a position in ACET in Q4 2022 and held it in 4 quarters. The position peaked at $110K in Q4 2022. 96 funds tracked by Wall St. Rank hold ACET as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Adicet Bio position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 289 Adicet Bio shares in Q1 2024, an estimated $8.74K.
  • Point72 Middle East FZE first reported a position in Adicet Bio in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's Adicet Bio position peaked at $110K in Q4 2022.
  • 96 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.